-
In 2005, major pharmaceutical companies are estimated to have spent $45-$50 billion on research and development. Yet only 17 drugs were approved for marketing by the FDA, says Dan McDonald, vice president of Thomson CenterWatch in Boston.
-
Clinical trials in the United States have trouble recruiting subjects, completing on time, and maintaining high quality and efficiency, and these problems are why major pharmaceutical companies and other sponsors are offering more business to international research organizations, experts say.
-
Researchers increasingly are told they need to involve participants in clinical trial design, but most would agree this is a difficult ideal to follow.
-
Master's degree programs in clinical research administration or management, as well as certificate programs, are gaining ground as training vehicles for people who work in health care or another professional field and would like to switch to clinical trials and research.
-
Community speakers bureau launched; FDA warns against use of unapproved drug products
-
Coleman RL. Obesity and endometrial cancer. Altern Ther Women's Health 2006;8:70.
-
O'Mathúna DP. Reiki for relaxation and pain relief. Altern Ther Women's Health 2006;8:65-68.
-
Brown D. Policosanol ineffective for treating hyperlipidemia. Altern Ther Women's health 2006;8:68-70.
-
Nearly 27% of surveyed hospitals—up from 18% in 2004—are offering complementary and alternative medicine (CAM) programs to the patients they serve.
-
Sasser H. Spirituality and health. Altern Med Alert 2006;9:101-104.
